Histamine-2 (H 2 ) antagonists can be safely removed from standard paclitaxel premedication regimens.

MLA

Foreman, Emma, et al. “Histamine-2 (H 2 ) Antagonists Can Be Safely Removed from Standard Paclitaxel Premedication Regimens.” British Journal of Clinical Pharmacology, vol. 88, no. 9, Sept. 2022, pp. 4191–98. EBSCOhost, https://doi.org/10.1111/bcp.15363.

APA

Foreman, E., Polwart, C., Walker, A., & Chambers, P. (2022). Histamine-2 (H 2 ) antagonists can be safely removed from standard paclitaxel premedication regimens. British Journal of Clinical Pharmacology, 88(9), 4191–4198. https://doi.org/10.1111/bcp.15363

Chicago

Foreman, Emma, Calum Polwart, Andrew Walker, and Pinkie Chambers. 2022. “Histamine-2 (H 2 ) Antagonists Can Be Safely Removed from Standard Paclitaxel Premedication Regimens.” British Journal of Clinical Pharmacology 88 (9): 4191–98. doi:10.1111/bcp.15363.